코데인계 진통제 시장 규모, 점유율 및 성장 분석 : 제형별, 적응증별, 유통경로별, 최종사용자별, 처방 유형별, 지역별 - 업계 예측(2026-2033년)

Global Codeine Painkillers Market size was valued at USD 5.82 Billion in 2024 and is poised to grow from USD 6.1 Billion in 2025 to USD 8.88 Billion by 2033, growing at a CAGR of 4.8% during the forecast period (2026-2033).

The global market for codeine painkillers revolves around the production and consumption of codeine-containing formulations, primarily aimed at mild to moderate pain relief and cough suppression. Codeine's prominence as a frequently prescribed opioid analgesic facilitates billions of treatment courses each year. The market's growth has been influenced by regulatory shifts, with codeine becoming a preferred option for cost-effective pain management. This trend has led to increased manufacturing in countries like India and the incorporation of codeine into over-the-counter products in Western Europe. Currently, there is a heightened demand for safer alternatives to stronger opioids, spurring investments in combination products that incorporate non-opioid agents, which offer effective pain relief while minimizing abuse potential. Additionally, the easing of prescription restrictions in Southeast Asia is expanding opportunities for over-the-counter codeine products and attracting foreign investment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Codeine Painkillers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Codeine Painkillers Market Segments Analysis

Global codeine painkillers market is segmented by formulation, indication, distribution channel, end user, prescription type and region. Based on formulation, the market is segmented into Tablets, Capsules, Oral Solutions and Combination Products. Based on indication, the market is segmented into Mild Pain, Moderate Pain and Postoperative Pain. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on end user, the market is segmented into Hospitals, Clinics and Homecare. Based on prescription type, the market is segmented into Prescription Only and Controlled Dispensing Programs. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Codeine Painkillers Market

The increasing prevalence of chronic musculoskeletal disorders has led to a growing demand for effective pain relief, making codeine a commonly prescribed analgesic for moderate to severe pain. Healthcare practitioners are increasingly acknowledging its effectiveness in alleviating long-lasting discomfort, resulting in a broader adoption within both primary care and specialty practices. This rising reliance on codeine contributes to a consistent demand, prompting manufacturers to enhance production capabilities and invest in improved formulations that promote patient adherence and therapeutic effectiveness. Furthermore, the preference for oral administration and the favorable safety profile compared to stronger opioids solidify codeine's position in pain management strategies, bolstering its market presence across various healthcare settings.

Restraints in the Global Codeine Painkillers Market

The Global Codeine Painkillers market faces significant restraints due to stringent regulations imposed by health authorities aimed at curbing dependence and minimizing adverse effects. These regulations require manufacturers to navigate complex compliance frameworks, involving extensive documentation, regular safety assessments, and restrictive labeling practices. Consequently, product development timelines are extended, and operational costs rise, resulting in increased barriers to entry and decreased flexibility in positioning products within the market. This cautious environment discourages rapid market expansion and new product introductions, as pharmaceutical companies must allocate resources towards monitoring programs, ultimately restricting their ability to penetrate the market effectively.

Market Trends of the Global Codeine Painkillers Market

The Global Codeine Painkillers market is experiencing a significant trend toward increased over-the-counter (OTC) accessibility, particularly in emerging markets. This shift stems from rising consumer demand for self-managed pain relief solutions amid challenges in accessing prescription services. As a result, pharmaceutical companies are enhancing distribution through pharmacies and retail chains while adapting their packaging, branding, and compliance strategies to align with evolving regulatory frameworks. To encourage responsible usage, firms are investing in educational campaigns tailored to diverse urban and rural communities. This trend highlights a growing consumer preference for convenient analgesic options, bolstered by advancements in telepharmacy services.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Codeine Painkillers Market Size by Formulation & CAGR (2026-2033)

• Market Overview
• Tablets
• Capsules
• Oral Solutions
• Combination Products

Global Codeine Painkillers Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Mild Pain
• Moderate Pain
• Postoperative Pain

Global Codeine Painkillers Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Codeine Painkillers Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Clinics
• Homecare

Global Codeine Painkillers Market Size by Prescription Type & CAGR (2026-2033)

• Market Overview
• Prescription Only
• Controlled Dispensing Programs

Global Codeine Painkillers Market Size & CAGR (2026-2033)

• North America (Formulation, Indication, Distribution Channel, End User, Prescription Type)
  • US
  • Canada
• Europe (Formulation, Indication, Distribution Channel, End User, Prescription Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Formulation, Indication, Distribution Channel, End User, Prescription Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Formulation, Indication, Distribution Channel, End User, Prescription Type)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Formulation, Indication, Distribution Channel, End User, Prescription Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Lifesciences Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Torrent Pharmaceuticals Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amneal Pharmaceuticals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STADA Arzneimittel AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sandoz Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perrigo Company plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations